Jump to content

User talk:Medradar

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Welcome!

Hello, Medradar, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful:

I hope you enjoy editing here and being a Wikipedian! Please sign your messages on discussion pages using four tildes (~~~~); this will automatically insert your username and the date. If you need help, check out Wikipedia:Questions, ask me on my talk page, or ask your question and then place {{helpme}} before the question on your talk page.

If you are interested in medicine-related themes, you may want to check out the Medicine Portal.
If you are interested in contributing more to medical related articles you may want to join WikiProject Medicine (signup here).


Again, welcome!  David Ruben Talk 20:16, 5 January 2009 (UTC)[reply]

Osteonecrosis of the

[edit]

I've responded to your comments at User talk:Dr. Imbeau, so wont repeat those points here (although I sadly note Dr Imbeau not edited since 29 October 2006, so not sure they are still around).

Separately though, the picture of "cumulative cases of ONj" (File:TimelineONJ1.jpg) - surely that is mistitled as it is the cumulative cases of ONj thought to be associated from bisphosphonates, given the article states ONj was first recognised some 150 years ago when bisphosphonates were yet to be developed ? The image's bottom key sets this out correctly, but the top header is thus imprecise :-) Could you tweak this ? Also the chart I guess is only based on FDA US reported cases and is not a worldwide count, the title of the chart should reflect this too.

Also with the picture, what is with the green line for number of guidelines published ? Clearly it is never going to reach 3000 guidelines and so be on a par with number of suspected adverse events and so seems unhelpful at best. The guideline numbers is also presumably US-only, and what counts here (State medical board guidelines, or revisions of that from the FDA - likely to be countable on fingers of one hand). Would a numerical value (i.e. 1, 3, 12) along the chart's bottom edge be more useful to see how number of cases is being reflected with increasing awareness and guideline coverage ? David Ruben Talk 20:16, 5 January 2009 (UTC)[reply]